UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo evidence derived from the study of peripheral arterial disease

Circulation (New York, N.Y.), 1997-07, Vol.96 (1), p.69-75

1997

Volltextzugriff (PDF)

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

Thrombosis and haemostasis, 1990, Vol.63 (2), p.204-207

1990

Volltextzugriff (PDF)

Low molecular weight heparins: are they interchangeable? No

Journal of thrombosis and haemostasis, 2003-01, Vol.1 (1), p.12-13

Nenci, G. G.

2003

Volltextzugriff (PDF)

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation

The Journal of clinical investigation, 1998-02, Vol.101 (3), p.667-676

1998

Volltextzugriff (PDF)

New pyridazinone derivatives as inhibitors of platelet aggregation

European journal of medicinal chemistry, 1995, Vol.30 (7), p.627-631

1995

Volltextzugriff (PDF)

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity : A phase II evaluation

Circulation (New York, N.Y.), 2000-11, Vol.102 (22), p.2726-2731

2000

Volltextzugriff (PDF)

Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism

Current pharmaceutical design, 2005-01, Vol.11 (30), p.3893-3918

2005

Volltextzugriff (PDF)

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor‐1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues

Cancer, 1996-03, Vol.77 (6), p.1079-1088

1996

Volltextzugriff (PDF)

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study

Thrombosis and haemostasis, 2001-11, Vol.86 (5), p.1181-1187

2001

Volltextzugriff (PDF)

Improvement of Walking Distance by Defibrotide in Patients with Intermittent Claudication: Results of a Randomized, Placebo-controlled Study (the DICLIS Study)

Thrombosis and haemostasis, 2000-05, Vol.83 (5), p.672-677

2000

Volltextzugriff (PDF)

Dermatan Sulphate as an Antithrombotic Drug

Pathophysiology of haemostasis and thrombosis, 2002-09, Vol.32 (5-6), p.303-307

Nenci, Giuseppe G.

2002

Volltextzugriff (PDF)

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Blood, 1993-11, Vol.82 (9), p.2704-2713

1993

Volltextzugriff (PDF)

Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests

Thrombosis and haemostasis, 1997-12, Vol.78 (6), p.1434-1437

1997

Volltextzugriff (PDF)

Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography--an overview analysis

Thrombosis and haemostasis, 1996-12, Vol.76 (6), p.887-892

1996

Volltextzugriff (PDF)

Thrombolytic Therapy for Thromboembolism of Vertebrobasilar Artery

Angiology, 1983-09, Vol.34 (9), p.561-571

1983

Volltextzugriff (PDF)

Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders

Trends in Pharmacological Sciences, 1991, Vol.12 (4), p.158-163

1991

Volltextzugriff (PDF)

Dermatan sulphate in patients with heparin‐induced thrombocytopenia

British journal of haematology, 1999-01, Vol.104 (1), p.87-89

1999

Volltextzugriff (PDF)

Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation

Gastroenterology (New York, N.Y. 1943), 1992-08, Vol.103 (2), p.641-646

1992

Volltextzugriff (PDF)

Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin

Haematologica (Roma), 2002-10, Vol.87 (10), p.1116

2002

Volltextzugriff (PDF)

Prolonged antithrombin activity of low-molecular-weight heparins : clinical implications for the treatment of thromboembolic diseases

Circulation (New York, N.Y.), 1995-11, Vol.92 (10), p.2819-2824

1995

Volltextzugriff (PDF)

Low molecular weight heparins for arterial thrombosis

Vascular medicine (London, England), 2000-11, Vol.5 (4), p.251-258

2000

Volltextzugriff (PDF)

Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition

Haematologica (Roma), 2001-03, Vol.86 (3), p.297

2001

Volltextzugriff (PDF)

Low‐dose aspirin in polycythaemia vera: a pilot study

British journal of haematology, 1997-05, Vol.97 (2), p.453-456

ITALIANO STUDIO POLICITEMIA (GISP), GRUPPO

1997

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Thrombosis and haemostasis, 1992-02, Vol.67 (2), p.203-208

1992

Volltextzugriff (PDF)

Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery

Thrombosis and haemostasis, 1996-02, Vol.75 (2), p.239-241

1996

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(103)

Sprache

Englisch
(103)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(97)
Science & Technology
(97)
Humans
(81)
Biological And Medical Sciences
(51)
Male
(47)
Medical Sciences
(47)
Hematology
(46)
Female
(42)
Cardiovascular System & Cardiology
(34)
Middle Aged
(34)
Peripheral Vascular Disease
(34)
Adult
(30)
Aged
(27)
Pharmacology. Drug Treatments
(27)
Blood. Blood Coagulation. Reticuloendothelial System
(18)
Pharmacology & Pharmacy
(14)
Double-Blind Method
(12)
General & Internal Medicine
(12)
Medicine, General & Internal
(12)
Blood Platelets - Metabolism
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo evidence derived from the study of peripheral arterial disease

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

Low molecular weight heparins: are they interchangeable? No

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation

New pyridazinone derivatives as inhibitors of platelet aggregation

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity : A phase II evaluation

Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor‐1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study

Improvement of Walking Distance by Defibrotide in Patients with Intermittent Claudication: Results of a Randomized, Placebo-controlled Study (the DICLIS Study)

Dermatan Sulphate as an Antithrombotic Drug

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests

Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography--an overview analysis

Thrombolytic Therapy for Thromboembolism of Vertebrobasilar Artery

Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders

Dermatan sulphate in patients with heparin‐induced thrombocytopenia

Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation

Inhibition of fluid phase and clot-bound thrombin by the thrombin exosite I ligand LU 58463: comparison with heparin and hirudin

Prolonged antithrombin activity of low-molecular-weight heparins : clinical implications for the treatment of thromboembolic diseases

Low molecular weight heparins for arterial thrombosis

Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition

Low‐dose aspirin in polycythaemia vera: a pilot study

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery

Suchergebnisse filtern